Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
10/2008
10/30/2008US20080267920 Monoparamunity inducers based on attenuated rabbit myxomaviruses
10/30/2008CA2684311A1 Microorganism detection method and apparatus
10/29/2008EP1985705A2 Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
10/29/2008EP1985703A2 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
10/29/2008EP1984388A2 Hpv antigens, vaccine compositions, and related methods
10/29/2008EP1869171B1 Virus purification using ultrafiltration
10/29/2008EP1441764B1 Antigen arrays comprising rankl for treatment of bone disease
10/29/2008EP1180155B1 Vector for integration of heterologous sequences into poxviral genomes
10/29/2008EP1035208B1 VARIANT LoxP SEQUENCES AND APPLICATION OF THE SAME
10/29/2008EP0610250B2 Porcine reproductive respiratory syndrome (prrs) vaccine and diagnostic
10/29/2008CN101293918A Shorten human papilloma virus 16 type L1 protein
10/29/2008CN100429321C Use of SARS coronary virus ORF8 region
10/29/2008CN100429230C Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor
10/29/2008CN100428961C Artificial recombination selection replication type adenovirus and application
10/28/2008US7442551 Lentiviral packaging constructs
10/28/2008US7442544 Viral vector in which gene for Sendai viral protein selected from NP, P, and L proteins is deleted or inactivated while all other gene functions are retained; use as expression vector in e.g. gene therapy; efficient system for reconstituting Sendai virus
10/28/2008US7442381 Alphavirus replicons and helper constructs
10/28/2008US7442379 Recombinant Newcastle disease virus RNA expression systems and vaccines
10/28/2008US7442378 Having mutation in viral nucleic acid encoding viral protein 2; bird and chicken vaccines
10/28/2008US7442159 selection of a virus comprising the steps of: (a) providing a virus encoding and displaying a fusion polypeptide, said fusion polypeptide comprising a heterologous polypeptide inserted into the sequence of a viral coat protein polypeptide, wherein said virus
10/28/2008CA2267207C Methods for detecting or assaying virus
10/23/2008WO2008125361A1 Method for the preparation of sulfated cellulose membranes and sulfated cellulose membranes
10/23/2008WO2008125360A1 Method for purification of viral proteins
10/23/2008WO2008125119A1 Adaptive mutations allow establishment of jfh1-based cell culture systems for hepatitis c virus genotype 4a
10/23/2008WO2008125117A1 Cell culture system of a hepatitis c genotype 3a and 2a chimera
10/23/2008US20080261289 Compositions comprising viruses and methods for concentrating virus preparations
10/23/2008US20080261271 Expression of hiv polypeptides and production of virus-like particles
10/23/2008US20080261197 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection
10/23/2008US20080260854 Sirna Molecules for the Treatment of Blood Vessels
10/23/2008US20080260789 Expressed in venom glands of spiders; polynucleotides; transgenic plant or insect
10/23/2008US20080260781 Proteosome influenza vaccine
10/23/2008US20080260780 Materials and methods relating to improved vaccination strategies
10/23/2008US20080260775 Modified Rna virus packaged with structural proteins and second virus; induce immunology response
10/23/2008US20080260698 Chimeric sindbis-western equine encephalitis virus and uses thereof
10/22/2008EP1983057A2 Improved AAV vectors for gene therapy
10/22/2008EP1983048A1 Novel protein expression system
10/22/2008EP1983047A1 Novel viral vector
10/22/2008EP1982727A1 Method for purification of viral proteins
10/22/2008EP1981976A2 Methods for profiling transcriptosomes
10/22/2008EP1981548A2 Enhanced production of infectious parvovirus vectors in insect cells
10/22/2008EP1266022B1 Cell-specific adenovirus vectors comprising an internal ribosome entry site
10/22/2008EP0828519B1 Recombinant viral vector system
10/22/2008CN101289658A Recombination virus particles for expressing 2-typed porcine circovirus nucleocapsid protein Cap gene
10/22/2008CN101289657A Recombination porcine parvovirus VP2 virus particles for expressing exogenous gene
10/22/2008CN101289656A Long term storage process for mosaic virus of pumpkins
10/22/2008CN101289655A Process for preparing porcine circovirus
10/21/2008US7439347 Hepatitis C virus non-structural NS3/4A fusion gene
10/21/2008US7439345 Supramolecular pairing system, its preparation and use
10/21/2008US7439065 Helper virus-free AAV production
10/21/2008US7439060 Independent helper virus packaging cell line for propagating viral vectors
10/21/2008US7439058 For use in vaccines
10/21/2008US7439052 Exposing human- or simian immunodeficiency virus to a delipidation process comprising solvent extraction using diisopropyl ether and/or 1-butanol to decrease lipid or cholesterol content of a viral envelope; vaccines; immunostimulants
10/21/2008US7439051 selecting phage resistant to blood inactivation using phage display library; identification of peptide-specific antibodies; peptide for complexing with a drug to protect the drug from antibody inactivation during delivery
10/21/2008US7439015 Methods for detecting DNA viruses
10/21/2008US7438919 An isolated protein; vaccines
10/21/2008US7438901 Virulent phages to control Listeria monocytogenes in foodstuffs and in food processing plants
10/21/2008US7438890 Binding peptides for carcinoembryonic antigen (CEA)
10/21/2008CA2426127C Method for producing virus rna polymerase
10/21/2008CA2289776C An infectious clone for human parainfluenza virus type 3
10/21/2008CA2230452C Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof
10/16/2008WO2008124015A1 Methods for purifying adeno-associated virus virions
10/16/2008WO2008094197A3 Chimeric influenza virus-like particles
10/16/2008WO2008061243A3 Respiratory syncytial virus-virus like particle (vlps)
10/16/2008WO2008054481A3 Improved inactivated influenza virus compositions
10/16/2008WO2008008276A3 Tetracycline repressor regulated oncolytic viruses
10/16/2008US20080254067 Process for the Production of an Influenza Vaccine
10/16/2008US20080254060 Attenuated viruses comprising modified NS1 genes, having an impaired ability to antagonize the cellular interferon response; decreased in vivo replication, virulence and increased attenuation; live cancer vaccines
10/16/2008US20080254059 Adenovirus Serotype 26 Vectors, Nucleic Acid and Viruses Produced Thereby
10/15/2008EP1980617A1 Improved expression of HIV polypeptides and production of virus-like particles
10/15/2008EP1980615A1 Polypeptide having affinity for envelope virus constituent and use thereof in transferring substance into cell
10/15/2008EP1483376B1 High throughput system for producing recombinant viruses using site-specific recombination
10/15/2008CN101287489A Production of multivalent virus like particles
10/15/2008CN101285056A Hog cholera recombinant adenovirus and use thereof for preparing hog cholera genetic engineering bacterin
10/15/2008CN101285055A Recombinant human interferon induced protein IV baculovirus
10/15/2008CN100425702C Lentiviral triplex DNA, and vectors and recombinant cells contg. same
10/15/2008CN100425701C Constructs for expression of plants
10/14/2008US7435588 Systems for detection and production of respiratory, herpes and enteric viruses
10/14/2008US7435434 Phage resistant bacteria
10/14/2008CA2315248C Protein expression in baculovirus vector expression systems
10/14/2008CA2190394C Recombinant viruses, preparation and use thereof in gene therapy
10/09/2008WO2008120570A1 Culture medium for production of protein or proliferation of virus
10/09/2008WO2007087410A3 Novel recombinant t4 phage particle containing hiv, h. pylori or cancer antigens and uses thereto
10/09/2008US20080248551 Methods and compositions for live attenuated viruses
10/09/2008US20080248064 Localization and Characterization of Flavivirus Envelope Gylcoprotein Cross-Reactive Epitopes and Methods for their Use
10/09/2008US20080248057 Multivalent immunogenic composition containing RSV subunit compostion and influenza virus preparation
10/09/2008US20080248042 Monoclonal antibody cross-reactive against infective agent causing a B-cell expansion and IgG-Fc
10/08/2008EP1978027A1 Full-length infectious cDNA clones of tick borne flavivirus
10/08/2008EP1977245A1 Method for determining the concentration of virus particles/virus antigens
10/08/2008CN101283088A Virus-interacting layered phyllosilicates and methods of inactivating viruses
10/08/2008CN101280316A Therapeutic vaccine for human cervical carcinoma
10/08/2008CN101280292A Virus velogen strain for porcine reproductive and respiratory syndrome, attenuated vaccine strain thereof and application thereof
10/08/2008CN100424094C Pharmaceutical compositions, and a method of preparing and isolating said pharmaceutical compositions, and use of said pharmaceutical compositions for prophylactic treatment of lesions and carcinomas
10/07/2008US7432347 Cytoplasmic polyhedrosis virus polyhedrin protein complex
10/07/2008US7432101 Production of poxviruses with adherent or non adherent avian cell lines
10/07/2008US7431934 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same
10/07/2008US7431932 Infecting the mixed cellular compositions with reovirus which selectively lyse the ras-mediated neoplastic cells in the mixed composition; reducing the risk of introducing or reintroducing neoplastic cells into the recipient
10/07/2008US7431930 Neutralizing epitopes for viruses
10/07/2008US7431929 For eliciting an immune response to smallpox virus ; vaccines having an increased level of safety, recombinant vaccinia viruses containing an inactivated E3L region
10/07/2008CA2296067C Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
10/02/2008WO2008118662A2 Imprinted polymeric materials for binding various targets such as viruses
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 267